Article | September 6, 2017

Protecting Today's Biologics With Gelled Phase Change Materials

Source: Cold Chain Technologies

As the biologics market continues to grow exponentially, the limitations of today’s thermal packaging utilizing phase change materials could have a considerable impact on the timely delivery of safe and effective medication. Gelled PCM eliminate these limitations and offer a more dependable future for the biopharma industry.

access the Article!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

Cold Chain Technologies